Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Caris Life Sciences, Inc.CAI · Entity 3706 | Director | August 14, 2026 | August 14, 2026 |
| GLAUKOS CorpGKOS · Entity 3510 | PRESIDENT & COO | August 11, 2026 | August 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Caris Life Sciences, Inc.
Report date August 14, 2026 · Filed August 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 29,321 |
Reported balance
After 2026-08-14 transaction · row 1
1 source rowRow 1 · 2026-08-14 · Grant · Acquired 13,192 · Balance 29,321 F1: Represents an award of restricted stock units which vest in accordance with the applicable grant agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units which vest in accordance with the applicable grant agreement.
GLAUKOS Corp
Report date August 11, 2026 · Filed August 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 72,588 |
Last balance in matching sequence
After 2026-08-11 transaction · row 6
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
6 source rowsRow 1 · 2026-08-11 · Exercise / conversion · Acquired 10,000 · Balance 82,588 F1: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Row 2 · 2026-08-11 · Exercise / conversion · Acquired 20,000 · Balance 102,588 F1: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Row 3 · 2026-08-11 · Exercise / conversion · Acquired 20,000 · Balance 122,588 F1: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Row 4 · 2026-08-11 · Exercise / conversion · Acquired 10,000 · Balance 132,588 F1: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Row 5 · 2026-08-11 · Sale · Disposed 27,963 · Balance 104,625 F2: This transaction was executed in multiple trades at prices ranging from $178.60 to $179.58). The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Row 6 · 2026-08-11 · Sale · Disposed 32,037 · Balance 72,588 F3: This transaction was executed in multiple trades at prices ranging from $179.68 to $180.60). The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $55.18 · Expires 2032-03-24 | Direct | 51,475 |
Reported balance
After 2026-08-11 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-08-11 · Exercise / conversion · Disposed 20,000 · Balance 51,475 F4: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $55.18 · Expires 2032-03-24 | Direct | 33,118 |
Reported balance
After 2026-08-11 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-08-11 · Exercise / conversion · Disposed 20,000 · Balance 33,118 F5: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer to the Reporting Person on March 24, 2022 in connection with his promotion to President and Chief Operating Officer, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals. F6: Total amount reported has been adjusted to correct a typographical error made in a Form 4 report filed by the Reporting Person on March 17, 2025, in which 13,721 stock options earned were erroneously reported as 13,271 stock options. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $48.46 · Expires 2033-03-22 | Direct | 26,751 |
Reported balance
After 2026-08-11 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-08-11 · Exercise / conversion · Disposed 10,000 · Balance 26,751 F7: These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $48.46 · Expires 2033-03-22 | Direct | 26,751 |
Reported balance
After 2026-08-11 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2026-08-11 · Exercise / conversion · Disposed 10,000 · Balance 26,751 F8: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 22, 2023, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
F2: This transaction was executed in multiple trades at prices ranging from $178.60 to $179.58). The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $179.68 to $180.60). The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period.
F5: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer to the Reporting Person on March 24, 2022 in connection with his promotion to President and Chief Operating Officer, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals.
F6: Total amount reported has been adjusted to correct a typographical error made in a Form 4 report filed by the Reporting Person on March 17, 2025, in which 13,721 stock options earned were erroneously reported as 13,271 stock options.
F7: These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years.
F8: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 22, 2023, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 20, 2024 Filed Dec 24, 2024 02:15 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,275 | $0.00 Strike: $69.30 | $0.00 |
DisclosureSEC source: 0001415889-24-030120 · form4-12242024_021251.xml · derivative · entry 6 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 431 Underlying: Common Stock · 2,275 shares Expires 2029-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: The option exercises reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2024. F7 · derivative.exercise_date: This option was granted on March 14, 2019 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date. Read SEC document |
| December 20, 2024 Filed Dec 24, 2024 02:15 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,053 | $0.00 Strike: $39.10 | $0.00 |
DisclosureSEC source: 0001415889-24-030120 · form4-12242024_021251.xml · derivative · entry 5 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,053 shares Expires 2030-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: The option exercises reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2024. F6 · derivative.exercise_date: This option was granted on March 12, 2020 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date. Read SEC document |
| December 20, 2024 Filed Dec 24, 2024 02:15 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 1,292 | $150.35 | $194,252.20 |
DisclosureSEC source: 0001415889-24-030120 · form4-12242024_021251.xml · nonDerivative · entry 4 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,169 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2024. F4 · price: This transaction was executed in multiple trades at prices ranging from $150.03 to $150.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person, and includes 324 shares of common stock of the Issuer that were purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| December 20, 2024 Filed Dec 24, 2024 02:15 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 2,036 | $149.54 | $304,463.44 |
DisclosureSEC source: 0001415889-24-030120 · form4-12242024_021251.xml · nonDerivative · entry 3 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 103,461 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2024. F3 · price: This transaction was executed in multiple trades at prices ranging from $149.01 to $149.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person, and includes 324 shares of common stock of the Issuer that were purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| December 20, 2024 Filed Dec 24, 2024 02:15 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 2,275 | $69.30 | $157,657.50 |
DisclosureSEC source: 0001415889-24-030120 · form4-12242024_021251.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,497 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person, and includes 324 shares of common stock of the Issuer that were purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| December 20, 2024 Filed Dec 24, 2024 02:15 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 1,053 | $39.10 | $41,172.30 |
DisclosureSEC source: 0001415889-24-030120 · form4-12242024_021251.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 103,222 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person, and includes 324 shares of common stock of the Issuer that were purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| December 20, 2024 Filed Jan 3, 2025 01:32 UTC | GLAUKOS Corp GKOS · Entity 3510 | Tax withholdingCommon Stock | 964 | $138.93 | $133,928.52 |
DisclosureSEC source: 0001415889-25-000248 · form4-01032025_010135.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,205 F1 · shares: Consists of shares withheld by the Issuer with respect to tax withholding obligations of the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on March 18, 2021. F2 · balance_after: Includes 74,475 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| October 30, 2024 Filed Nov 1, 2024 21:30 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,275 | $69.30 Strike: $69.30 | $157,657.50 |
DisclosureSEC source: 0001415889-24-025918 · form4-11012024_051101.xml · derivative · entry 3 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,706 Underlying: Common Stock · 2,275 shares Expires 2029-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: The option exercises reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2024. F5 · derivative.exercise_date: This option was granted on March 14, 2019 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date. Read SEC document |
| October 30, 2024 Filed Nov 1, 2024 21:30 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 2,275 | $138.97 | $316,156.75 |
DisclosureSEC source: 0001415889-24-025918 · form4-11012024_051101.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,169 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2024. F3 · price: This transaction was executed in multiple trades at prices ranging from $138.60 to $139.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person, and includes 324 shares of common stock of the Issuer that were purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| October 30, 2024 Filed Nov 1, 2024 21:30 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 2,275 | $69.30 | $157,657.50 |
DisclosureSEC source: 0001415889-24-025918 · form4-11012024_051101.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person, and includes 324 shares of common stock of the Issuer that were purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| September 19, 2024 Filed Sep 23, 2024 23:15 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Option (Right to Buy) · Derivative | 14,640 | $0.00 Strike: $55.18 | $0.00 |
DisclosureSEC source: 0001415889-24-023870 · form4-09232024_110924.xml · derivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,379 Underlying: Common Stock · 14,640 shares Expires 2032-03-24 F1 · shares: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating and Governance Committee of the Issuer's Board of Directors determined on September 19, 2024 that certain of the operational targets had been achieved. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets. F2 · derivative.exercise_date: 25% of the portion of the option reported herein will vest and become exercisable in September 2024. 25% of the portion of the option reported herein will vest and become exercisable in December 2024. 25% of the portion of the option reported herein will vest and become exercisable in May 2025, and the remaining 25% will vest and become exercisable in September 2025. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 21:25 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $55.18 | $0.00 |
DisclosureSEC source: 0001415889-24-022146 · form4-08232024_090851.xml · derivative · entry 6 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,442 Underlying: Common Stock · 2,500 shares Expires 2032-03-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: The option exercises reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2024. F7 · derivative.exercise_date: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer to the Reporting Person on March 24, 2022 in connection with his promotion to President and Chief Operating Officer, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 21:25 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $55.18 | $0.00 |
DisclosureSEC source: 0001415889-24-022146 · form4-08232024_090851.xml · derivative · entry 5 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,739 Underlying: Common Stock · 2,500 shares Expires 2032-03-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: The option exercises reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2024. F6 · derivative.exercise_date: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 21:25 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 580 | $130.03 | $75,417.40 |
DisclosureSEC source: 0001415889-24-022146 · form4-08232024_090851.xml · nonDerivative · entry 4 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,169 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2024. F4 · price: This transaction was executed in multiple trades at prices ranging from $130.02 to $130.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person, and includes 324 shares of common stock of the Issuer that were purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 21:25 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 4,420 | $129.27 | $571,373.40 |
DisclosureSEC source: 0001415889-24-022146 · form4-08232024_090851.xml · nonDerivative · entry 3 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,749 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2024. F3 · price: This transaction was executed in multiple trades at prices ranging from $129.01 to $130.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person, and includes 324 shares of common stock of the Issuer that were purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 21:25 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 2,500 | $55.18 | $137,950.00 |
DisclosureSEC source: 0001415889-24-022146 · form4-08232024_090851.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 107,169 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person, and includes 324 shares of common stock of the Issuer that were purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 21:25 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 2,500 | $55.18 | $137,950.00 |
DisclosureSEC source: 0001415889-24-022146 · form4-08232024_090851.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,669 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person, and includes 324 shares of common stock of the Issuer that were purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 21:10 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,250 | $69.30 Strike: $69.30 | $155,925.00 |
DisclosureSEC source: 0001415889-24-019438 · form4-07092024_090713.xml · derivative · entry 3 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,981 Underlying: Common Stock · 2,250 shares Expires 2029-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: The option exercises reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2024. F5 · derivative.exercise_date: This option was granted on March 14, 2019 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 21:10 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 2,250 | $121.39 | $273,127.50 |
DisclosureSEC source: 0001415889-24-019438 · form4-07092024_090713.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 101,845 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2024. F3 · price: This transaction was executed in multiple trades at prices ranging from $121.28 to $121.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 21:10 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 2,250 | $69.30 | $155,925.00 |
DisclosureSEC source: 0001415889-24-019438 · form4-07092024_090713.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:35 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $55.18 | $0.00 |
DisclosureSEC source: 0001415889-24-015681 · form4-06052024_110616.xml · derivative · entry 5 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,942 Underlying: Common Stock · 2,500 shares Expires 2032-03-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · kind: The option exercises reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2024. F7 · derivative.exercise_date: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer to the Reporting Person on March 24, 2022 in connection with his promotion to President and Chief Operating Officer, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:35 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 190 | $114.73 | $21,798.70 |
DisclosureSEC source: 0001415889-24-015681 · form4-06052024_110616.xml · nonDerivative · entry 4 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 101,845 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2024. F5 · price: This transaction was executed in multiple trades at prices ranging from $114.72 to $114.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:35 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 936 | $114.22 | $106,909.92 |
DisclosureSEC source: 0001415889-24-015681 · form4-06052024_110616.xml · nonDerivative · entry 3 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,035 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2024. F4 · price: This transaction was executed in multiple trades at prices ranging from $113.62 to $114.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:35 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 1,374 | $112.84 | $155,042.16 |
DisclosureSEC source: 0001415889-24-015681 · form4-06052024_110616.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,971 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2024. F3 · price: This transaction was executed in multiple trades at prices ranging from $112.44 - $113.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:35 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 2,500 | $55.18 | $137,950.00 |
DisclosureSEC source: 0001415889-24-015681 · form4-06052024_110616.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,345 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| May 10, 2024 Filed May 14, 2024 20:43 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,395 | $0.00 Strike: $55.18 | $0.00 |
DisclosureSEC source: 0001415889-24-013136 · form4-05142024_080543.xml · derivative · entry 3 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,239 Underlying: Common Stock · 2,395 shares Expires 2032-03-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: The option exercises reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F5 · derivative.exercise_date: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. Read SEC document |
| May 10, 2024 Filed May 14, 2024 20:43 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 2,395 | $110.56 | $264,791.20 |
DisclosureSEC source: 0001415889-24-013136 · form4-05142024_080543.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 101,845 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $110.36 to $111.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| May 10, 2024 Filed May 14, 2024 20:43 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 2,395 | $55.18 | $132,156.10 |
DisclosureSEC source: 0001415889-24-013136 · form4-05142024_080543.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,240 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| May 06, 2024 Filed May 8, 2024 21:21 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 105 | $0.00 Strike: $55.18 | $0.00 |
DisclosureSEC source: 0001415889-24-012635 · form4-05082024_090556.xml · derivative · entry 3 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,634 Underlying: Common Stock · 105 shares Expires 2032-03-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The option exercises reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F4 · derivative.exercise_date: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. Read SEC document |
| May 06, 2024 Filed May 8, 2024 21:21 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 105 | $110.36 | $11,587.80 |
DisclosureSEC source: 0001415889-24-012635 · form4-05082024_090556.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 101,845 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| May 06, 2024 Filed May 8, 2024 21:21 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 105 | $55.18 | $5,793.90 |
DisclosureSEC source: 0001415889-24-012635 · form4-05082024_090556.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 101,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| May 02, 2024 Filed May 6, 2024 21:23 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,059 | $0.00 Strike: $69.30 | $0.00 |
DisclosureSEC source: 0001415889-24-012358 · form4-05062024_090515.xml · derivative · entry 6 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,231 Underlying: Common Stock · 2,059 shares Expires 2029-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · kind: The option exercises reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F8 · derivative.exercise_date: This option was granted on March 14, 2019 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date. Read SEC document |
| May 02, 2024 Filed May 6, 2024 21:23 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 165 | $107.58 | $17,750.70 |
DisclosureSEC source: 0001415889-24-012358 · form4-05062024_090515.xml · nonDerivative · entry 5 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 101,845 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F6 · price: This transaction was executed in multiple trades at prices ranging from $107.42 to $107.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| May 02, 2024 Filed May 6, 2024 21:23 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 577 | $106.39 | $61,387.03 |
DisclosureSEC source: 0001415889-24-012358 · form4-05062024_090515.xml · nonDerivative · entry 4 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,010 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F5 · price: This transaction was executed in multiple trades at prices ranging from $106.08 to $106.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| May 02, 2024 Filed May 6, 2024 21:23 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 672 | $105.31 | $70,768.32 |
DisclosureSEC source: 0001415889-24-012358 · form4-05062024_090515.xml · nonDerivative · entry 3 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,587 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F4 · price: This transaction was executed in multiple trades at prices ranging from $104.96 to $105.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| May 02, 2024 Filed May 6, 2024 21:23 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 645 | $104.43 | $67,357.35 |
DisclosureSEC source: 0001415889-24-012358 · form4-05062024_090515.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 103,259 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $103.95 to $104.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| May 02, 2024 Filed May 6, 2024 21:23 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 2,059 | $69.30 | $142,688.70 |
DisclosureSEC source: 0001415889-24-012358 · form4-05062024_090515.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 103,904 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| April 08, 2024 Filed Apr 11, 2024 00:20 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 59,801 | $0.00 Strike: $41.69 | $0.00 |
DisclosureSEC source: 0001415889-24-010674 · form4-04112024_120431.xml · derivative · entry 6 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 59,801 shares Expires 2027-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · kind: The option exercises reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F7 · shares: The amount reported reflects an adjustment in the number of stock options outstanding in the amount of 15,872, as a result of a forfeiture of such stock options back to the Reporting Person in accordance with the terms of a domestic relations order issued in connection with a marital dissolution. F8 · derivative.exercise_date: This option was granted on May 5, 2017 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date. F7 · balance_after: The amount reported reflects an adjustment in the number of stock options outstanding in the amount of 15,872, as a result of a forfeiture of such stock options back to the Reporting Person in accordance with the terms of a domestic relations order issued in connection with a marital dissolution. Read SEC document |
| April 08, 2024 Filed Apr 11, 2024 00:20 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 86 | $102.13 | $8,783.18 |
DisclosureSEC source: 0001415889-24-010674 · form4-04112024_120431.xml · nonDerivative · entry 5 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 101,845 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| April 08, 2024 Filed Apr 11, 2024 00:20 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 8,191 | $101.28 | $829,584.48 |
DisclosureSEC source: 0001415889-24-010674 · form4-04112024_120431.xml · nonDerivative · entry 4 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 101,931 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F5 · price: This transaction was executed in multiple trades at prices ranging from $101.03 to $102.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| April 08, 2024 Filed Apr 11, 2024 00:20 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 41,068 | $100.52 | $4,128,155.36 |
DisclosureSEC source: 0001415889-24-010674 · form4-04112024_120431.xml · nonDerivative · entry 3 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 110,122 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F4 · price: This transaction was executed in multiple trades at prices ranging from $100.02 to $101.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| April 08, 2024 Filed Apr 11, 2024 00:20 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 10,456 | $99.64 | $1,041,835.84 |
DisclosureSEC source: 0001415889-24-010674 · form4-04112024_120431.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 151,190 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $99.01 to $100.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| April 08, 2024 Filed Apr 11, 2024 00:20 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 59,801 | $41.69 | $2,493,103.69 |
DisclosureSEC source: 0001415889-24-010674 · form4-04112024_120431.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 161,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| April 05, 2024 Filed Apr 9, 2024 23:40 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,457 | $0.00 Strike: $55.18 | $0.00 |
DisclosureSEC source: 0001415889-24-010612 · form4-04092024_110435.xml · derivative · entry 3 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,739 Underlying: Common Stock · 2,457 shares Expires 2032-03-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F5 · derivative.exercise_date: The option was granted by the Issuer on March 24, 2022 and vests upon the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. Read SEC document |
| April 05, 2024 Filed Apr 9, 2024 23:40 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 2,457 | $96.81 | $237,862.17 |
DisclosureSEC source: 0001415889-24-010612 · form4-04092024_110435.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 101,845 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $96.57 to $97.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| April 05, 2024 Filed Apr 9, 2024 23:40 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 2,457 | $55.18 | $135,577.26 |
DisclosureSEC source: 0001415889-24-010612 · form4-04092024_110435.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,302 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| April 04, 2024 Filed Apr 5, 2024 22:15 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 200 | $0.00 Strike: $55.18 | $0.00 |
DisclosureSEC source: 0001415889-24-010452 · form4-04052024_100443.xml · derivative · entry 6 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,196 Underlying: Common Stock · 200 shares Expires 2032-03-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F4 · derivative.exercise_date: The option was granted by the Issuer on March 24, 2022 and vests upon the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. Read SEC document |
| April 04, 2024 Filed Apr 5, 2024 22:15 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 200 | $96.57 | $19,314.00 |
DisclosureSEC source: 0001415889-24-010452 · form4-04052024_100443.xml · nonDerivative · entry 4 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 101,845 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| April 04, 2024 Filed Apr 5, 2024 22:15 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 200 | $55.18 | $11,036.00 |
DisclosureSEC source: 0001415889-24-010452 · form4-04052024_100443.xml · nonDerivative · entry 3 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,045 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| April 03, 2024 Filed Apr 5, 2024 22:15 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 200 | $0.00 Strike: $55.18 | $0.00 |
DisclosureSEC source: 0001415889-24-010452 · form4-04052024_100443.xml · derivative · entry 5 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,396 Underlying: Common Stock · 200 shares Expires 2032-03-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F4 · derivative.exercise_date: The option was granted by the Issuer on March 24, 2022 and vests upon the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.